[HTML][HTML] Expression of CD52 in peripheral T-cell lymphoma

PP Piccaluga, C Agostinelli, S Righi, PL Zinzani… - …, 2007 - haematologica.org
PP Piccaluga, C Agostinelli, S Righi, PL Zinzani, SA Pileri
Haematologica, 2007haematologica.org
Peripheral T-cell lymphoma unspecified (PTCL/U) is a rare tumor characterized by poor
treatment response and a dismal prognosis. We studied CD52 expression in 97 PTCL/U
cases by immunohistochemistry on tissue-microarrays. Furthermore, CD52 gene expression
was studied in 28 cases for which RNA was available. We found that CD52 is expressed in
approximately 40% of PTCLs/U at the same level as in normal T-lymphocytes. Although
other factors may play a role in the in vivo response to alemtuzumab, an anti-CD52 …
Abstract
Peripheral T-cell lymphoma unspecified (PTCL/U) is a rare tumor characterized by poor treatment response and a dismal prognosis. We studied CD52 expression in 97 PTCL/U cases by immunohistochemistry on tissue-microarrays. Furthermore, CD52 gene expression was studied in 28 cases for which RNA was available. We found that CD52 is expressed in approximately 40% of PTCLs/U at the same level as in normal T-lymphocytes. Although other factors may play a role in the in vivo response to alemtuzumab, an anti-CD52 monoclonal antibody, the estimation of CD52 expression may provide a rationale for the selection of patients with a higher probability of treatment response.
haematologica.org